Researchers examined the relationship between the pancreatic microbiome and patient characteristics as well as the duodenal microbiome.
Exxua (previously named Travivo) is a novel oral serotonin 1A receptor agonist.
Annual pay, growth potential, cost of living are among the important considerations.
Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.
These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.
Researchers sought to explore the relationship between the initiation of MS treatment and patient-reported symptoms and health-related quality of life.
Researchers evaluate whether antibiotic use in patients with decompensated cirrhosis and without infection prevented hospital-acquired infection.
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
The NDA is supported by two 2 positive interim analyses from the phase 3 REGENERATE trial that included patients with biopsy-proven stage 2 or 3 liver fibrosis due to NASH.
The OPTN policy revision may increase some Black kidney candidates’ total waiting time, which is a major factor in their transplant priority for organ offers.
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Investigators sought to evaluate the effectiveness of psychotherapy for comorbid symptoms of anxiety, depression, and OCD among individuals with ASD.
In a prospective, longitudinal study, researchers assessed the effect of demographics, pre-COVID-19 comorbidities, index COVID-19 hospitalization metrics, and life stressors on 6- and 12-month outcome metrics in adult patients post-COVID-19 hospitalization.
Patients with acute appendicitis between 2000 and 2020 were evaluated for complications on the basis of having a mental health diagnosis.
Researchers evaluated oral health as a determinant of 3-month hospitalizations in compensated or decompensated outpatients with cirrhosis.
Recent COVID-19 updates include a successful pacing program for people with long COVID symptoms, a blood marker for post-vaccine myocarditis, and the first home test-to-treat program.
The EULAR issued recommendations for the screening and prophylaxis of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases.
The sNDA is supported by data from two phase 3 studies that evaluated the efficacy and safety of brexpiprazole in patients with agitation associated with Alzheimer dementia.